The story of Viagra and its effect on the pharmaceutical sector presents a challenging question regarding its continued viability as an investment. Initially a remarkable success, generating billions , generic competition has considerably eroded financial returns. While established pharmaceutical firms maintain patents on related therapies and expl

The outlook of companies tied to flagship drugs like Viagra presents a challenging investment scenario . While the initial rise of copyright, fueled by Viagra's extraordinary popularity, generated substantial profits , the expiry in key territories has introduced considerable volatility. Investors are now grappling with the consequences of rival me